KARAKTERISTIK INPUT DAN LUARAN NEONATUS DENGAN TERAPI SURFAKTAN METODE INTUBATION-SURFACTANT-EXTUBATION (INSURE)

INPUT AND OUTPUT CHARACTERISTICS OF NEONATES WITH SURFACTANT THERAPY USING INTUBATION-SURFACTANT-EXTUBATION (INSURE) METHOD

  • Nenden Nursyamsi Agustina Departemen Ilmu Kesehatan Anak, Fakultas Kedokteran, Universitas Jenderal Soedirman
  • Agus Fitrianto Departemen Ilmu Kesehatan Anak, RSUD Prof. Dr. Margono Soekarjo

Abstract

ABSTRAK
Terapi surfaktan diberikan pada bayi prematur dengan Hyaline Membrane Disease (HMD) yang mengalami Respiratory Distress Syndrome (RDS). Pemberian terapi surfaktan dengan metode Intubation – Surfactant – Extubation (INSURE) merupakan salah satu metode yang lebih minimal invasif dibandingkan ventilasi mekanik konvensional. Penelitian ini bertujuan mengetahui karakteristik input dan luaran neonatus yang mendapat terapi surfaktan metode INSURE di RSUD Prof. Dr. Margono Soekarjo. Desain penelitian yang digunakan adalah deskriptif dari data sekunder berupa rekam medis dan laporan pasien Neonatal Intensive Care Unit (NICU) periode Juli 2017-Juli 2019. Sampel penelitian sebanyak 11 neonatus yang mendapat terapi surfaktan metode INSURE di RSUD Prof. Dr. Margono Soekarjo. Teknik pengambilan sampel menggunakan total sampling. Karakteristik input terdiri atas jenis kelamin, berat badan lahir (BBL), status asfiksia, kehamilan dengan risiko penyulit, dan waktu pemberian surfaktan. Karakteristik luaran terdiri atas klinis selama perawatan, length of survival, dan status pulang. Asfiksia sedang terjadi pada 90,9% pasien. Sebanyak 36,4% pasien dengan berat badan lahir sangat rendah (BBLSR) dan berat badan lahir amat sangat rendah (BBLASR) dan 27,3% pasien berat badan lahir rendah (BBLR). Karakteristik input dari faktor ibu didominasi kehamilan dengan risiko penyulit. Neonatus yang mendapatkan surfaktan > 6 jam pertama setelah lahir sebesar 72,7%. Karakteristik luaran klinis neonatus selama perawatan adalah 54,5% mengalami respiratory distress dan 45,4% HMD grade III, 54,6% hanya mampu bertahan ≤7 hari, dan 45,4% bayi berhasil bertahan sampai tidak memerlukan Continuous Positive Airway Pressure (CPAP) lagi. Tiga bayi hidup sampai pulang dan 2 meninggal karena sepsis. Karakteristik input terbanyak pasien adalah laki-laki, asfiksia sedang, BBLSR atau BBLASR, dan lahir dari ibu dengan risiko penyulit. Karakteristik luaran terbanyak pasien adalah respiratory distress, HMD grade III, dan hanya mampu bertahan ≤7 hari.


 


ABSTRACT
The surfactant replacement therapy was effective for neonates suffering from Respiratory Distress Syndrome (RDS) with Hyaline Membrane Disease (HMD). Surfactant therapy using Intubation – Surfactant – Extubation (INSURE) method is less invasive than conventional mechanical ventilation. This study was conducted to find out the input and output characteristics of neonates who got surfactant therapy with the INSURE method at Margono Soekarjo General State Hospital. It was a descriptive study by utilizing secondary data from the medical record and NICU patient reports for the period July 2017-July 2019. Total sampling technique was were used in this study. Input characteristics consisted of sexes, birth weight, asphyxia status, pregnancy with complicating risk, and time of surfactant administration. Output characteristics consisted of a clinical duration of treatment, length of survival, and discharge status. Eleven neonates got surfactant therapy using INSURE method in Margono Soekarjo General State Hospital for the period July 2017-July 2019. Moderate asphyxia occurred at 90.9%. There were 36.4% of patients with Very-Low-Birth-Weight and Extremely-Low-Birth-Weight and 27.3% patients with Low-Birth-Weight. Input characteristics of maternal factors were dominated by pregnancy with complicating risks. Neonates receiving surfactants > 6 hours first of life were 72.7%. Characteristics of neonatal clinical outcomes during treatment were 54.5% respiratory distress and 45.4% HMD grade III. There were 54,6% of patients died before 7 days of life and 45,4% of patients survived until Continuous Positive Airway Pressure (CPAP) weaning. There were three patients discharged from hospital and two patients died because of sepsis. The input characteristics of most patients were male, moderate asphyxia, BBLSR or BBLASR, and born to mothers with a risk of complications. The outcome characteristics of most patients are respiratory distress, HMD grade III, and length of survival ≤7 days.


 

References

Altman, M., Vanpée, M., Cnattingius, S., Norman, M. 2013. Risk factors for acute respiratory morbidity in moderately preterm infants. Paediatric and Perinatal Epidemiology 27(2): 172–181. doi: 10.1111/ppe.12035.

Azzabi, O., Selmi, I., Maherzi, A. 2016. Intubation-surfactant-extubation strategy in a medical resource-limited department: a prospective study. Journal of Tropical Pediatrics 62(2): 169–170. doi: 10.1093/tropej/fmv074.

Barkhuff, W. D. and Soll, R. F. 2019. Novel surfactant administration techniques: will they change outcome? Neonatology 115(4): 411–422. doi: 10.1159/000497328.

De Bisschop, B., Derriks, F., Cools, F. 2020. Early predictors for intubation-surfactant-extubation failure in preterm infants with neonatal respiratory distress syndrome: a systematic review. Neonatology 117(1): 33-45. doi: 10.1159/000501654.

Bunt, J. E. H., Carnielli, V. P., Darcos Wattimena, J. L., Hop, W. C., Sauer, P. J., Zimmermann, L.J. 2000. The effect in premature infants of prenatal corticosteroids on endogenous surfactant synthesis as measured with stable isotopes. American Journal of Respiratory and Critical Care Medicine 162(3): 844–849. doi: 10.1164/ajrccm.162.3.9906139.

Chen, C., Tian, T., Liu, L., Zhang, J., Fu, H. 2018. Gender-related efficacy of pulmonary surfactant in infants with respiratory distress syndrome. Medicine 97(17): e0425. doi: 10.1097/MD.0000000000010425.

Danaei, N., Seddigh, M., Ghorbani, R., Nooripour, S. 2017. Effective factors of INSURE method failure in treatment of respiratory distress syndrome in preterm infants. International Journal of Pediatrics 5(11): 6069–6076. doi: 10.22038/ijp.2017.26022.2221.

Ethawi, Y.H., Abou Mehrem, A., Minski, J., Ruth, C, A., Davis, P. G. 2016. High frequency jet ventilation versus high frequency oscillatory ventilation for pulmonary dysfunction in preterm infants. Cochrane database Syst Rev 2016 May 6(5): CD010548. doi: 10.1002/14651858.CD010548.

Fallahi, M., Borhani, S., Radfar, M., Abbasi, F. 2016. Determining the effect of surfactant instillation time in the prognosis of RDS. IOSR Journal Of Pharmacy 6(11): 19–23.

Garib, M., Salama, N., Deraz, S. 2015. Early versus late extubation after surfactant replacement therapy for respiratory distress syndrome. Egyptian Pediatric Association Gazette 63(1): 1–5. doi: 10.1016/j.epag.2015.02.003.

Hansen, A. K., Wisborg, K., Uldbjerg, N., Henriksen, T. B. 2008. Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study. BMJ 336(7635): 85–87. doi: 10.1136/bmj.39405.539282.BE.

Ho, J. J., Subramaniam, P., Davis, P. G. 2015. Continuous distending pressure for respiratory distress in preterm infants. Cochrane Database of Systematic Reviews Jul 4(7): CD002271. doi: 10.1002/14651858.CD002271.

Juvé-Udina, M. E., Fabrellas-Padrés, N., Delgado-Hito, P., Hurtado-Pardos, B., Marti-Cavallé, M., Gironés-Nogué, M., et al. 2015. Newborn physiological immaturity: a concept analysis. Adv Neonatal Care 15(2): 86–93. doi: 10.1097/ANC.0000000000000162.

Kalkan, I., Heljić, S., Čengić, A., Mišanović, V., Anić, D., Jonuzi, F., et al. 2007. Surfactant administration in premature infants with RDS. Signa Vitae 2(1): 21-24 P. Available at: https://hrcak.srce.hr/11966 (Accessed: 8 March 2020).

Kemenkes RI. 2019. Profil Kesehatan Indonesia 2018 [Indonesia Health Profile 2018]. Available at: http://www.depkes.go.id/resources/download/pusdatin/profil-kesehatan-indonesia/Data-dan-Informasi_Profil-Kesehatan-Indonesia-2018.pdf.

Koh, J. W., Kim, J. W., Chang, Y. P. 2018. Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants. Korean Journal of Pediatrics 61(10): 315–321. doi: 10.3345/kjp.2018.06296.

Mathai, S. S., Raju, U., Kanitkar, M. 2007. Management of respiratory distress in the newborn. Medical journal, Armed Forces India 63(3): 269–72. doi: 10.1016/S0377-1237(07)80152-3.

Melamed, N., Klinger, G., Tenenbaum-Gavish, K., Herscovici, T., Linder, N., Hod, M., et al. 2009. Short-term neonatal outcome in low-risk, spontaneous, singleton, late preterm deliveries. Obstet Gynecol 114(2,Part1): 253–260. doi: 10.1097/AOG.0b013e3181af6931.`

Miyahara, J., Sugiura, H., Ohki, S. 2019. The evaluation of the efficacy and safety of non-invasive neurally adjusted ventilatory assist in combination with INtubation-SURfactant-Extubation technique for infants at 28 to 33 weeks of gestation with respiratory distress syndrome. SAGE Open Medicine 7: 205031211983841. doi: 10.1177/2050312119838417.

Ognean, M. L., Stoicescu, S. M., Boantă, O., Năstase, L., Gliga, C., Cucerea, M. 2016. Intubation-surfactant: extubation on continuous positive pressure ventilation. who are the best candidates? The Journal of Critical Care Medicine 2(2): 73–79. doi: 10.1515/jccm-2016-0010.

Rahmadani, R. U. Sulistyono, A., Yulistiani, Yahya, M. 2015. Phosphatidylglycerol study as fetal lung maturation parameter after. Folia Medica Indonesiana 52(4): 264–269.

Roberts, D. Medley, N., Dalziel, S. R. 2017. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews Mar 21(3): CD004454. doi: 10.1002/14651858.CD004454.

Seaborn, T., Simard, M., Provost, P. R., Piedboeuf, B., Tremblay, Y. 2010. Sex hormone metabolism in lung development and maturation. Trends in Endocrinology & Metabolism 21(12): 729–738. doi: 10.1016/j.tem.2010.09.001.

Sekar, K., Fuentes, D., Krukas-hempel, M. R., Ernst, F. R. 2019. Health economics and outcomes of surfactant treatments for respiratory distress syndrome among preterm infants in us level iii/iv neonatal intensive care units. The Journal of Pediatric Pharmacology and Therapeutics 24(2): 117–127. doi: 10.5863/1551-6776-24.2.117.

Shim, G.-H. 2017. Update of minimally invasive surfactant therapy. Korean Journal of Pediatrics 60(9): 273. doi: 10.3345/kjp.2017.60.9.273.

Sotiriadis, A., Makrydimas, G., Papatheodorou, S., Ioannidis, J. P. A., McGoldrick, E. 2018. Corticisteroids for preventing neonatal respiratory morbidity after Elective caesarean section at term (Review). Cochrane Database Syst Rev 2018(8): CD006614. doi: 10.1002/14651858.CD006614.pub3.www.cochranelibrary.com.

Tochie, J. N., Choukem, S. P., Langmis, R. N., Barla, E., Koki-Ndombo, P. 2016. Neonatal respiratory distress in a reference neonatal unit in Cameroon: an analysis of prevalence, predictors, etiologies and outcomes. Pan African Medical Journal 24: 1–10. doi: 10.11604/pamj.2016.24.152.7066.

Townsel, C. D., Emmer, S. F., Campbell, W. A., Hussain, N. 2017. Gender differences in respiratory morbidity and mortality of preterm neonates. Front Pediatr Jan 30(5): 6. doi: 10.3389/fped.2017.00006.

UNICEF, WHO, World Bank Group, United Nations. 2018. Levels and Trends in Child Mortality Report 2018. Available at: https://www.un.org/en/development/desa/population/publications/mortality/child-mortality-report-2018.asp (Accessed: March 9 2019).

Wang, J., Liu, X., Zhu, T., Yan, C. 2015. Analysis of neonatal respiratory distress syndrome among different gestational segments. International Journal of Clinical and Experimental Medicine 8(9): 16273–16279.

Wang, L., Chen, L., Li, R., Zao, J., Wu, X., Li, X., et al. 2015. Efficacy of surfactant at different gestational ages for infants with respiratory distress syndrome. International Journal of Clinical and Experimental Medicine 8(8): 13783–13789.

WHO. 2017. Causes of child mortality, World Health Organization. World Health Organization. Available at: https://www.who.int/gho/child_health/mortality/causes/en/ (Accessed: December 31 2019).
Published
2020-06-03
How to Cite
AGUSTINA, Nenden Nursyamsi; FITRIANTO, Agus. KARAKTERISTIK INPUT DAN LUARAN NEONATUS DENGAN TERAPI SURFAKTAN METODE INTUBATION-SURFACTANT-EXTUBATION (INSURE). Mandala Of Health : A Scientific Journal, [S.l.], v. 13, n. 1, p. 1-12, june 2020. ISSN 2615-6954. Available at: <http://jos.unsoed.ac.id/index.php/mandala/article/view/2289>. Date accessed: 10 july 2020. doi: https://doi.org/10.20884/1.mandala health.2020.13.1.2289.